Intercalated BSc in Pharmacology & Innovative Therapeutics
Barts & the London intends to offer internal and external MB BS students, who have completed year 2, 3 or 4 of their programme, the opportunity to intercalate for one academic year and gain a BSc in Pharmacology and Innovative Therapeutics. This new course is based upon the final year (level 6) of the existing BSc degree programme run by the Institute. This intercalated degree will comprise of a research-oriented project, a number of specialist topics in pharmacology such as drug design, translational pharmacology, innovative therapeutics and clinical trials as well as the role of regulatory agencies in therapeutic innovation and commercial exploitation.
This degree focusses on the research environment and will provide students with an appreciation of the scientific foundations of clinical medicine, thereby informing their subsequent career-related decisions. During their studies with us, students are encouraged students to think critically, and to study on a deeper level, the scientific basis of pharmacology and the clinical trials industry.
Students will be expected to complete a 45 credit laboratory-based research project that will promote their development of higher critical and analytical skills and also study four 15 credit in-depth pharmacology specific modules such as drug design for pharmacologists, translational pharmacology and innovative therapeutics, clinical trials and regulatory affairs, and a literature review based around classic papers and current topics in pharmacology which is designed to develop skills of critical analysis in reading scientific papers and to promote the ability to present data clearly and accurately.
In addition, students will complete one 15 credit elective module out of at least four elective module choices. Elective modules offered include, stem cells and regenerative medicine, advanced immunology, cancer biology and the molecular basis of personalised medicine.
Summary for 2019/20 with unit values
Students studying for the intercalated BSc programme will complete four 15-credit taught modules, a 45-credit research project plus one 15-credit elective module. An indicative list of modules is shown below, specific guidance on the selection of option modules that match research projects will be provided to students by tutors and the programme director.
Core Modules: (60 credits)
- Drug Design for Pharmacologists
- Translational Pharmacology and Innovative Therapeutics
- Clinical Trials and Regulatory Affairs
- Classic Papers and Current Topics in Pharmacology
Elective Module options may include: (15 credits)
- Stem Cells and Regenerative Medicine
- Advanced Immunology
- Cancer Biology
- Molecular Basis of Personalist Medicine